Generali Investments CEE’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.6M Sell
27,981
-1,644
-6% -$192K 0.17% 149
2026
Q1
$3.56M Sell
29,625
-435
-1% -$50.2K 0.19% 146
2025
Q4
$3.16M Hold
30,060
0.22% 149
2025
Q3
$2.52M Sell
30,060
-668
-2% -$55K 0.19% 143
2025
Q2
$2.43M Hold
30,728
0.2% 140
2025
Q1
$2.76M Sell
30,728
-956
-3% -$89.3K 0.26% 124
2024
Q4
$3.15M Buy
+31,684
New +$3.27M 0.32% 103

Other funds holding MRK

Generali Investments CEE's MRK Position: Q2 2026 in Review

Generali Investments CEE reduced its Merck (MRK) stake by 5.5% in Q2 2026, selling an estimated $192K and leaving 27,981 shares worth $3.6M. The position accounts for 0.17% of the portfolio, ranked #149.

Generali Investments CEE first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. 2,345 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Generali Investments CEE held 27,981 shares of Merck worth $3.6M as of Q2 2026.
  • Generali Investments CEE sold 1,644 Merck shares in Q2 2026, an estimated $192K.
  • Merck made up 0.17% of Generali Investments CEE's portfolio in Q2 2026, its #149 holding.
  • Generali Investments CEE first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • 2,345 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Generali Investments CEE's 13F filing for Q2 2026, filed 13 Jul 2026.